CFG
36
12
ABT
54
4
PH
60
5
CTAS
36
8
IRM
33
5
PRU
39
3
LRCX
56
4
PNC
48
6
NWS
69
5
ROP
44
6
IR
46
3
HRB
40
3
MA
60
5
GILD
55
5
VTR
44
4
CMCSA
49
3
TROW
37
8
TAP
57
6
URBN
67
3
ORCL
49
3
CFG
36
12
ABT
54
4
PH
60
5
CTAS
36
8
IRM
33
5
PRU
39
3
LRCX
56
4
PNC
48
6
NWS
69
5
ROP
44
6
IR
46
3
HRB
40
3
MA
60
5
GILD
55
5
VTR
44
4
CMCSA
49
3
TROW
37
8
TAP
57
6
URBN
67
3
ORCL
49
3
Financhill
Back

MEI Pharma 10K Form

Sell
34

MEIP
MEI Pharma

Last Price:
$2.38
Seasonality Move:
-3.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MEIP News And Ratings

See the #1 stock for the next 7 days that we like better than MEIP

MEIP Financial Statistics

Sales & Book Value

Annual Sales: $65.3M
Cash Flow: $-11.5M
Price / Cash Flow: 0
Annual Sales: $3.73
Price / Book: 0.67

Profitability

EPS (TTM): -6.99000
Net Income (TTM): $-46.6M
Gross Margin: $40.7M
Return on Equity: 0%
Return on Assets: 0%

MEI Pharma Earnings Forecast

Key MEI Pharma Financial Ratios

  • The Gross Profit Margin over the past 20 years for MEIP is 100.01%.
  • The Selling, General & Administrative Expenses for MEIP have been equal to 35.68% of Gross Profit Margin.
  • The Research & Development expenses have been 25.36% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

MEI Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MEIP
CUSIP: 55279B
Website: meipharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0.94
Forward P/E Ratio: 0

MEIP Technical Analysis vs Fundamental Analysis

Sell
34
MEI Pharma (MEIP) is a Sell

Is MEI Pharma a Buy or a Sell?

  • MEI Pharma stock is rated a Sell
    The current MEI Pharma [MEIP] share price is $2.50. The Score for MEIP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.